DANNI ELDRED: Open Payments
NPI 1780214551 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,112 in 35 payments from 20 companies in 2025. Trend: 2023 $1,262 · 2024 $862 · 2025 $1,112
Food & beverage: $913Education: $199
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $274 |
| GlaxoSmithKline, LLC. | 4 | $106 |
| SEAGEN INC. | 1 | $100 |
| Daiichi Sankyo Inc. | 3 | $71 |
| Novartis Pharmaceuticals Corporation | 2 | $54 |
| Lilly USA, LLC | 2 | $52 |
| Genentech USA, Inc. | 2 | $51 |
| Astellas Pharma US Inc | 2 | $50 |
| BeiGene USA, Inc. | 2 | $48 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $38 |
Products named: RYBREVANT, ERLEADA, OJJAARA, VERZENIO, Padcev, Enhertu, YONSA, TALVEY.
Industry payments across CO — which companies pay providers there.
